Literature DB >> 8552410

Isotype-specific characterization of antibody responses to Onchocerca volvulus in putatively immune individuals.

G R Stewart1, L Elson, E Araujo, R Guderian, T B Nutman, J E Bradley.   

Abstract

Isotype/subclass-specific antibody responses to adult Onchocerca volvulus extract (OvAg) were assessed by both ELISA and immunoblotting for a group of putatively immune individuals (PIs, n = 29) from a hyperendemic area in Ecuador and for a group of infected individuals (INFs, n = 470) from the same regions. As a group, the PIs have been previously shown to possess lower levels of OvAg specific IgG1, IgG2, IgG3 and IgG4 than INF's but semi-quantitative analysis revealed that the relative proportions of these subclasses differs between the two groups. The IgG of the PI group contained a higher proportion of IgG3 and a lower proportion of IgG4 than the INF group. The frequency distribution of IgG3 responses was similar for the PI and INF groups. The frequency distributions for IgG1, IgG4 and IgE were significantly different between the PI and INF groups. A subgroup of the PIs were identified from frequency distributions and multivariate plots of individual isotype responses as having antibody responses (mainly IgG4) possibly indicative of cryptic infection. High IgE responses were exclusive to INF individuals, and a rare response type of high IgG3 with negligible levels of other isotypes/subclasses was seen only in the PI group. However, the majority of the PIs had negligible responses for all antibody classes. Immunoblots demonstrated no obvious differences in qualitative recognition between the PIs and INFs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8552410     DOI: 10.1111/j.1365-3024.1995.tb00904.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  7 in total

1.  Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response.

Authors:  P J Cooper; I Espinel; M Wieseman; W Paredes; M Espinel; R H Guderian; T B Nutman
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Population biology of human onchocerciasis.

Authors:  M G Basáñez; M Boussinesq
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

3.  Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.

Authors:  Angus J MacDonald; Prasad S D Turaga; Carolyn Harmon-Brown; Tracy J Tierney; Kristine E Bennett; Maggie C McCarthy; Scott C Simonek; Peter A Enyong; Daniel W Moukatte; Sara Lustigman
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  The novel cuticular collagen Ovcol-1 of Onchocerca volvulus is preferentially recognized by immunoglobulin G3 from putatively immune individuals.

Authors:  G R Stewart; Y Zhu; W Parredes; T I Tree; R Guderian; J E Bradley
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

5.  Immunoglobulin G (IgG) subclass and IgE responses in human paragonimiases caused by three different species.

Authors:  Y Kong; A Ito; H J Yang; Y B Chung; S Kasuya; M Kobayashi; Y H Liu; S Y Cho
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

6.  Human immune responses to infective stage larval-specific chitinase of filarial parasite, Onchocerca volvulus, Ov-CHI-1.

Authors:  Yang Wu; Gillian Egerton; James S McCarthy; Thomas B Nutman; Albert E Bianco
Journal:  Filaria J       Date:  2003-03-14

Review 7.  Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi.

Authors:  Bin Zhan; Maria Elena Bottazzi; Peter J Hotez; Sara Lustigman
Journal:  Front Cell Infect Microbiol       Date:  2022-04-04       Impact factor: 6.073

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.